361 related articles for article (PubMed ID: 31130573)
1. Successful reduction of ACTH secretion in a case of intractable Cushing's disease with pituitary Crooke's cell adenoma by combined modality therapy including temozolomide.
Tanaka S; Yamamoto M; Morita M; Takeno A; Kanazawa I; Yamaguchi T; Yamada S; Inoshita N; Oki Y; Kurosaki M; Sugimoto T
Endocr J; 2019 Aug; 66(8):701-708. PubMed ID: 31130573
[TBL] [Abstract][Full Text] [Related]
2. Temozolomide therapy for aggressive pituitary Crooke's cell corticotropinoma causing Cushing's Disease - a case report with literature review.
Gilis-Januszewska A; Wilusz M; Pantofliński J; Turek-Jabrocka R; Sokołowski G; Sowa-Staszczak A; Kluczyński Ł; Pach D; Zieliński G; Hubalewska-Dydejczyk A
Endokrynol Pol; 2018; 69(3):306-312. PubMed ID: 29319131
[TBL] [Abstract][Full Text] [Related]
3. Long-term complete remission of Crooke's corticotropinoma after temozolomide treatment.
Kurowska M; Tarach JS; Malicka J; Zieliński G; Maksymowicz M; Denew P
Endokrynol Pol; 2016; 67(5):526-533. PubMed ID: 27828691
[TBL] [Abstract][Full Text] [Related]
4. Aggressive Cushing's Disease: Molecular Pathology and Its Therapeutic Approach.
Yamamoto M; Nakao T; Ogawa W; Fukuoka H
Front Endocrinol (Lausanne); 2021; 12():650791. PubMed ID: 34220707
[TBL] [Abstract][Full Text] [Related]
5. Crooke's Changes In Cushing's Syndrome Depends on Degree of Hypercortisolism and Individual Susceptibility.
Oldfield EH; Vance ML; Louis RG; Pledger CL; Jane JA; Lopes MB
J Clin Endocrinol Metab; 2015 Aug; 100(8):3165-71. PubMed ID: 26147609
[TBL] [Abstract][Full Text] [Related]
6. High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease.
Takeshita A; Inoshita N; Taguchi M; Okuda C; Fukuhara N; Oyama K; Ohashi K; Sano T; Takeuchi Y; Yamada S
Eur J Endocrinol; 2009 Oct; 161(4):553-9. PubMed ID: 19589911
[TBL] [Abstract][Full Text] [Related]
7. A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing's syndrome.
Reincke M; Ritzel K; Oßwald A; Berr C; Stalla G; Hallfeldt K; Reisch N; Schopohl J; Beuschlein F
Eur J Endocrinol; 2015 Oct; 173(4):M23-32. PubMed ID: 25994948
[TBL] [Abstract][Full Text] [Related]
8. The coexistence of infundibular pituicytoma and Cushing's disease due to pituitary adenoma: A case report.
Gezer E; Selek A; Cetinarslan B; Canturk Z; Tarkun I; Ceylan S
Endocr Regul; 2019 Oct; 53(4):263-267. PubMed ID: 31734654
[TBL] [Abstract][Full Text] [Related]
9. Case report: ACTH-secreting pituitary carcinoma metastatic to the liver in a patient with a history of atypical pituitary adenoma and Cushing's disease.
Joehlin-Price AS; Hardesty DA; Arnold CA; Kirschner LS; Prevedello DM; Lehman NL
Diagn Pathol; 2017 Apr; 12(1):34. PubMed ID: 28420444
[TBL] [Abstract][Full Text] [Related]
10. Crooke's cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma.
George DH; Scheithauer BW; Kovacs K; Horvath E; Young WF; Lloyd RV; Meyer FB
Am J Surg Pathol; 2003 Oct; 27(10):1330-6. PubMed ID: 14508394
[TBL] [Abstract][Full Text] [Related]
11. A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule.
Timmers HJ; van Ginneken EM; Wesseling P; Sweep CG; Hermus AR
J Endocrinol Invest; 2006 Nov; 29(10):934-9. PubMed ID: 17185905
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin and somatostatin receptors in Cushing's disease.
Hofland LJ
Mol Cell Endocrinol; 2008 May; 286(1-2):199-205. PubMed ID: 18221833
[TBL] [Abstract][Full Text] [Related]
13. MGMT expression in pituitary corticotroph adenomas and its relationship to clinical, pathological, and ultrastructural parameters in patients with Cushing's disease.
Witek P; Maksymowicz M; Szamotulska K; Piaścik A; Wojciechowska-Luźniak A; Stasiewicz A; Witek J; Zieliński G
Folia Neuropathol; 2020; 58(4):357-364. PubMed ID: 33480240
[TBL] [Abstract][Full Text] [Related]
14. Crooke's hyalinization in silent corticotroph adenoma: report of two cases.
Roncaroli F; Faustini-Fustini M; Mauri F; Asioli S; Frank G
Endocr Pathol; 2002; 13(3):245-9. PubMed ID: 12446925
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Survival After Transformation of an Adrenocorticotropic Hormone-Secreting Pituitary Macroadenoma to a Silent Corticotroph Pituitary Carcinoma.
Rotman LE; Vaughan TB; Hackney JR; Riley KO
World Neurosurg; 2019 Feb; 122():417-423. PubMed ID: 30447452
[TBL] [Abstract][Full Text] [Related]
16. Comparison of ACTH secretion in Cushing's adenoma and clinically silent corticotroph adenoma by cell immunoblot assay.
Kojima Y; Suzuki S; Yamamura K; Ohhashi G; Yamamoto I
Endocr J; 2002 Jun; 49(3):285-92. PubMed ID: 12201210
[TBL] [Abstract][Full Text] [Related]
17. Cushing's disease: results of treatment and factors affecting outcome.
Ammini AC; Bhattacharya S; Sahoo JP; Philip J; Tandon N; Goswami R; Jyotsna VJ; Khadgawat R; Chumber S; Seth A; Karak AK; Sharma BS; Chandra PS; Suri A; Sharma MS; Kale SS; Singh M
Hormones (Athens); 2011; 10(3):222-9. PubMed ID: 22001133
[TBL] [Abstract][Full Text] [Related]
18. [Corticotroph adenoma].
Guignat L; Assie G; Bertagna X; Bertherat J
Presse Med; 2009 Jan; 38(1):125-32. PubMed ID: 19041214
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of 11-beta-hydroxysteroid dehydrogenase type 2 and glucocorticoid receptor in subclinical Cushing's disease due to pituitary macroadenoma.
Ebisawa T; Tojo K; Tajima N; Kamio M; Oki Y; Ono K; Sasano H
Endocr Pathol; 2008; 19(4):252-60. PubMed ID: 19048413
[TBL] [Abstract][Full Text] [Related]
20. Rare case of Cushing's disease due to double ACTH-producing adenomas, one located in the pituitary gland and one into the stalk.
Mendola M; Dolci A; Piscopello L; Tomei G; Bauer D; Corbetta S; Ambrosi B
Hormones (Athens); 2014; 13(4):574-8. PubMed ID: 25402386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]